Acute exacerbation of COPD: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
Line 18: | Line 18: | ||
* Heart failure |
* Heart failure |
||
== Clinical |
== Clinical Manifestations == |
||
* History |
* History |
Revision as of 14:22, 20 July 2020
Definition
- Worsening respiratory symptoms, including dyspnea, cough, sputum production, or change in sputum
Etiology
- Infections (bacterial or viral)
- Air pollution
- Pulmonary embolism
- Congestive heart failure
Pathophysiology
Differential Diagnosis
- Pneumonia
- Pulmonary embolism
- Heart failure
Clinical Manifestations
- History
- Signs & Symptoms
Investigations
- CXR r/o PNA
- ECG, troponins r/o ACS
- CBC
- ABG in severe exacerbation
- Sputum cultures to help guide later therapy
- Spirometry at some point during their hospitalization, if it's the first presentation
Management
- Puffers
- Ipratropium; can transition later to tiotropium
- MDI with aerochamber or nebulizer (no difference)
- Steroids
- Prednisone 40mg for 5 days
- Antibiotics if purulent/sputum change
- Non-invasive ventilation
- Decreases mortality and prevents intubation
- Indicated if any of the following:
- Respiratory acidosis (pH <7.35 and pCO
2>45) - Severe dyspnea with increased work of breathing
- Resistant hypoxia despite supplemental oxygen
- Respiratory acidosis (pH <7.35 and pCO
Prognosis
- 11% in-hospital mortality
- 23-33% 6-month or 1-year mortality
- 50% 2-year mortality